(Q36756356)

16 August 2017

1 reference

title

Neurobiology of dopamine in schizophrenia (English)

1 reference

16 August 2017

0 references

2

Anissa Abi-Dargham

1 reference

16 August 2017

Olivier Guillin

1

1 reference

PubMed ID

17349856

16 August 2017

Marc Laruelle

series ordinal

3

1 reference

16 August 2017

1 January 2007

1 reference

International Review of Neurobiology

16 August 2017

1 reference

16 August 2017

78

1 reference

16 August 2017

1-39

1 reference

Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies

16 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Prefrontal dopamine D1 receptors and working memory in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Decreased density of tyrosine hydroxylase-immunoreactive axons in the entorhinal cortex of schizophrenic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

The functional anatomy of basal ganglia disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

The experimental reproduction of amphetamine psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Differential distribution of tyrosine hydroxylase fibers on small and large neurons in layer II of anterior cingulate cortex of schizophrenic brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Striatal dopamine D2 receptors in tardive dyskinesia: PET study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Cloning and expression of a rat D2 dopamine receptor cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopaminergic control of synaptic plasticity in the dorsal striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H]mazindol.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Regulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase by dopaminergic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Molecular diversity of the dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopamine D2 receptors in schizophrenia studied in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Molecular pathology of schizophrenia: more than one disease process?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

[3H] GBR 12935 binding to the dopamine uptake site in post-mortem brain tissue in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Presynaptic dopaminergic function in the striatum of schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopamine in schizophrenia: a review and reconceptualization

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

[3H]raclopride binding to brain tissue from subjects with schizophrenia: methodological aspects.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Molecular cloning and expression of the gene for a human D1 dopamine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Primate globus pallidus and subthalamic nucleus: functional organization

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopamine D3 receptors expressed by all mesencephalic dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopamine tone regulates D1 receptor trafficking and delivery in striatal neurons in dopamine transporter-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Evolving behavior in the clinical and experimental amphetamine (model) psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

The basolateral amygdala-ventral striatal system and conditioned place preference: further evidence of limbic-striatal interactions underlying reward-related processes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Prefrontal cortical projections to the striatum in macaque monkeys: evidence for an organization related to prefrontal networks

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Recent advances in the molecular biology of dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopaminergic sensitization: implications for the pathogenesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Genes and the parsing of cognitive processes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Working memory dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

D(1) receptors in prefrontal cells and circuits

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Gating of information flow within the limbic system and the pathophysiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

The primate substantia nigra and VTA: integrative circuitry and function.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Striatonigrostriatal Pathways in Primates Form an Ascending Spiral from the Shell to the Dorsolateral Striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

D1 receptor activation enhances evoked discharge in neostriatal medium spiny neurons by modulating an L-type Ca2+ conductance.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopamine receptor subtype imbalance in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

[3H]GBR-12935 binding sites in human striatal membranes: binding characteristics and changes in parkinsonians and schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Multiple output channels in the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopamine transporter change in drug-naı̈ve schizophrenia: an imaging study with 99mTc-TRODAT-1

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Linking the family of D2 receptors to neuronal circuits in human brain: insights into schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: an effect mediated by ventral tegmental area.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Multiple receptors for dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopamine, the prefrontal cortex and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

A postmortem study of frontal cortical dopamine D1 receptors in schizophrenics, psychiatric controls, and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Altered dopaminergic function and negative symptoms in drug-free patients with schizophrenia. [123I]-iodobenzamide SPECT study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Augmentation of prefrontal cortical monoaminergic activity inhibits dopamine release in the caudate nucleus: an in vivo neurochemical assessment in the rhesus monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Primate cingulostriatal projection: limbic striatal versus sensorimotor striatal input

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 study.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Imaging D2 receptor occupancy by endogenous dopamine in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Increased dopamine transmission in schizophrenia: relationship to illness phases

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

D2 dopamine receptor gene expression by cholinergic neurons in the rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Intracellular modulation of NMDA receptor function by antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Neuromodulatory actions of dopamine on synaptically-evoked neostriatal responses in slices

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Provocative tests with psychostimulant drugs in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Prediction of relapse in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopaminergic mechanisms in idiopathic and drug-induced psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Increased brain dopamine and dopamine receptors in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

The estimated density of D2 striatal receptors in schizophrenia. A study with positron emission tomography and 76Br-bromolisuride.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

The binding of both [3H]nemonapride and [3H]raclopride is increased in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopamine receptor mRNA expression in human striatum and neocortex

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Clozapine potently stimulates mesocortical dopamine neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopamine receptors: from structure to function

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

From motivation to action: functional interface between the limbic system and the motor system.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopamine D1 and D2 receptor antagonism differentially modulates stimulation of striatal neurotransmitter levels by N-methyl-D-aspartic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Localization of dopamine D4 receptors in GABAergic neurons of the primate brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Bidirectional regulation of DARPP-32 phosphorylation by dopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopamine-mediated regulation of striatal neuronal and network interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Increased dopamine-receptor sensitivity in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopaminergic systems. Dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Biphasic modulation of evoked [3H]D-aspartate release by D-2 dopamine receptors in rat striatal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerised tomography study.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

[3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Elevated dopa decarboxylase activity in living brain of patients with psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Beyond the dopamine hypothesis. The neurochemical pathology of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Are Striatal Dopamine D4 Receptors Increased in Schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

DOPAMINE RECEPTOR ASYMMETRY IN SCHIZOPHRENIA

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Increased [3H] raclopride binding sites in postmortem brains from schizophrenic violent suicide victims.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Long-term haloperidol elevates dopamine D4 receptors by 2-fold in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Selective up-regulation of dopamine D1 receptors in dendritic spines by NMDA receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Brain dopamine receptors in schizophrenia: PET problems

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Bimodal Distribution of Dopamine Receptor Densities in Brains of Schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopamine D4 receptors elevated in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Novel dopamine receptor subtypes as targets for antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Glutamate/dopamine D1/D2 balance in the basal ganglia and its relevance to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopamine receptor subtypes colocalize in rat striatonigral neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Coordinated Expression of Dopamine Receptors in Neostriatal Medium Spiny Neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

In vivo measurement of the vesicular monoamine transporter in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Effect of apomorphine infusion on dopamine synthesis rate relates to dopaminergic tone

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Dopamine D2 receptor density estimates in schizophrenia: a positron emission tomography study with 11C-N-methylspiperone

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Pharmacology and behavioral pharmacology of the mesocortical dopamine system

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Implications of normal brain development for the pathogenesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Mesocortical dopaminergic function and human cognition

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

The nature of interactions involving prefrontal and striatal dopamine systems

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Developing a neuronal model for the pathophysiology of schizophrenia based on the nature of electrophysiological actions of dopamine in the prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Clozapine preferentially increases dopamine release in the rhesus monkey prefrontal cortex compared with the caudate nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Cloning and expression of human and rat D1 dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

Regulation of striatal aromatic L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978001-1

7 January 2021

10.1016/S0074-7742(06)78001-1

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17349856